Hong Zhang

Hong Zhang

Auto-generated profile, based on publicly available information

Hong Zhang

Radiation Oncology Branch, National Cancer Institute, Bethesda, Maryland

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2020 in npj Precision Oncology
Verified
Journal Article
Open access
PDF file
SNSylvia S. W. Ng
Sylvia S. W. Ng
HZHong Zhang
Hong Zhang
LWLisa Wang
Lisa Wang
DCDeborah Citrin
Deborah Citrin
LDLaura A. Dawson
Laura A. Dawson
Plasma levels of soluble factors early during hepatocellular carcinoma (HCC) stereotactic body radiotherapy (SBRT) were evaluated in relation to radiation liver injury, tumor response, and risk of early death. No significant differences were found in baseline plasma levels of AFP, CXCL1, and HGF amongst HCC patients with different Child Pugh scores. Higher levels of sTNFRII (P < 0.001), and lower levels of sCD40L (P < 0.001) and CXCL1 (P = 0.01) following one to two fractions of SBRT were noted in patients who developed liver toxicity vs. those who did not. High circulating levels of AFP (HR 2.16, P = 0.04), sTNFRII (HR 2.27, P = 0.01), and sIL-6R (HR 1.99, P = 0.03) early during SBRT were associated with increased risk of death 3 months post treatment. Plasma levels of the studied factors early during SBRT were not associated with tumor response. A pro-inflammatory systemic environment is associated with development of liver toxicity and increased risk of early death following SBRT.

2 October 2025 in Clinical Cancer Research
Verified
Journal Article
Open access
AKAnson T. Ku
Anson T. Ku
USUma Shankavaram
Uma Shankavaram
STShana Y. Trostel
Shana Y. Trostel
HZHong Zhang
Hong Zhang
SKSumeyra Kartal
Sumeyra Kartal
DCDeborah E. Citrin
Deborah E. Citrin
Purpose: Clinical risk grouping based on PSA, tumor grade, and disease extent guides treatment intensity for localized prostate cancer. However, many patients with intermediate- or high-risk disease treated with external beam radiotherapy (EBRT) and androgen deprivation therapy (ADT) still develop biochemical recurrence (BCR). Early identification of patients at high risk for BCR could enable personalized treatment strategies. Experimental Design: We prospectively enrolled 29 patients with intermediate- or high-risk prostate cancer undergoing EBRT and ADT. Pretreatment biopsies (n = 60) underwent whole-transcriptome microarray and whole-exome sequencing. Patients received multiparametric MRI at baseline and 6 months after treatment, with a median follow-up of 6 years. Gene expression differences between patients with and without BCR were analyzed using pathway tools and validated in external datasets. A novel TGF-β gene signature was derived and tested across multiple cohorts (median follow-up: 5–11 years). Results: TGF-β activity was significantly associated with BCR in the discovery cohort (P = 0.0081) and correlated with PTEN/TP53 alterations (P = 0.0246) and baseline multiparametric MRI tumor volume (P = 0.026). TGF-β activity also predicted metastasis-free survival (P = 0.037) and, in an independent cohort (n = 265), was prognostic for BCR-free (P = 0.05), metastasis-free (P < 0.001), and overall survival (P < 0.001). Conclusions: TGF-β activity is a dominant feature of intermediate- to unfavorable-risk prostate tumors prone to biochemical failure after EBRT with ADT and may serve as an independent prognostic biomarker beyond existing clinical criteria.

15 February 2022 in Inflammatory Bowel Diseases
Verified
Journal Article
Open access
PDF file
HLHui Li
Hui Li
HSHong Shu
Hong Shu
YXYing Xie
Ying Xie
HZHong Zhang
Hong Zhang
MCMingming Cui
Mingming Cui
FTFeng Tian
Feng Tian
To the Editors: Hypoganglionosis (HG) is a rare condition characterized by a reduced number of ganglion cells within the colonic submucosal (Meissner) and myenteric (Auerbach) plexuses. The most common clinical manifestations are chronic constipation or pseudo-obstruction.1 Definitive diagnosis is only possible by full-thickness biopsy; therefore, the condition is difficult to diagnose preoperatively. Herein, we present a rare case of recurrent intestinal obstruction and intestinal ulcers, which was finally diagnosed as multisegmental HG after 3 operations. A 56-year-old Chinese man was admitted to hospital in September 2018 with symptoms of recurrent bowel obstruction for 1 year. Colonoscopy showed ulcers around the hepatic flexure. Computed tomography enterography showed gross dilation of the ascending and transverse colon ( Figure 1A). Right hemicolectomy was performed, and Crohn’s disease was suspected postoperatively. However, constipation recurred immediately. In February 2019, he visited our hospital with intestinal bleeding. Computed tomography enterography showed obvious dilation of...

15 December 2025
Verified
Other
Open access
AKAnson T. Ku
Anson T. Ku
USUma Shankavaram
Uma Shankavaram
STShana Y. Trostel
Shana Y. Trostel
HZHong Zhang
Hong Zhang
SKSumeyra Kartal
Sumeyra Kartal
DCDeborah E. Citrin
Deborah E. Citrin
Multivariable analysis tables of the combined RTOG 9202, 9413, and 9902 cohorts

15 December 2025
Verified
Other
Open access
AKAnson T. Ku
Anson T. Ku
USUma Shankavaram
Uma Shankavaram
STShana Y. Trostel
Shana Y. Trostel
HZHong Zhang
Hong Zhang
SKSumeyra Kartal
Sumeyra Kartal
DCDeborah E. Citrin
Deborah E. Citrin
Associations between MRI tumor volumes and transcriptional signatures